| Literature DB >> 24084175 |
Abstract
Effective development of targeted therapies to prevent and treat delirium requires an understanding of the underlying physiologic processes. Historically, delirium has been considered a reflection of diffuse cerebral metabolic insufficiency, which may be a result of some combination of abnormal blood flow, abnormal energy metabolism, abnormal neurotransmission, and abnormal cellular maintenance processes. Perspectives on the pathophysiology underlying hepatic encephalopathy, sepsis-associated encephalopathy, critical illness delirium, and alcohol withdrawal delirium are discussed. Given the diverse etiologic mechanisms, it is likely that the pathophysiology underlying delirium is also quite diverse. Additional investigation is required to identify therapeutic targets for prevention and treatment.Entities:
Mesh:
Year: 2013 PMID: 24084175 DOI: 10.1097/WNP.0b013e3182a73e04
Source DB: PubMed Journal: J Clin Neurophysiol ISSN: 0736-0258 Impact factor: 2.177